mRNA Log2 expression comparisons between non-tumor control and GBM specimen, respectively, were as follows: HSPA5, 10.38 ± 0.01 vs. 11.56 ± 0.02, p < 0.001; HSP90B1, 8.36 ± 0.08 vs. 8.98 ± 0.02, p < 0.001. This evidence concerns the gene HSP90B1 and glioblastoma.